Exhibit 10.62
SECURITIES PURCHASE
AGREEMENT
SECURITIES PURCHASE
AGREEMENT (the “
Agreement ”), dated as of June 27, 2008, by and
among Averion International Corp., a Delaware corporation, with
principal offices located at 225 Turnpike Road, Southborough,
Massachusetts 01772 (the “ Company ”), and the
investors listed on the Schedule of Buyers attached hereto
(each, a “ Buyer ” and, collectively, the
“ Buyers ”). Capitalized terms used and
not defined elsewhere in this Agreement have the respective
meanings assigned to such terms in the Appendix
hereto.
WHEREAS:
A.
The Company and the Buyers are
executing and delivering this Agreement in reliance upon the
exemption from securities registration afforded by Rule 506 of
Regulation D (“ Regulation D ”) as
promulgated by the United States Securities and Exchange Commission
(the “ SEC ”) under the Securities Act of 1933,
as amended (the “ 1933 Act ”).
B.
The Buyers, severally and not
jointly, desire to purchase from the Company, and the Company
wishes to sell to the Buyers, upon the terms and conditions stated
in this Agreement:
(1)
Secured senior notes, in the form
attached as Exhibit A , in the aggregate principal
amount of $2,000,000 (together with any promissory notes or other
securities issued in exchange or substitution therefor or
replacement thereof, and as any of the same may be amended,
supplemented, restated or modified and in effect from time to time,
the “ Notes ”) shall be purchased by the Buyers
on the Closing Date (as defined below) for a total aggregate
principal amount of Notes equal to $2,000,000; and
(2)
Shares of Common Stock as set forth
on the Schedule of Buyers (the “ Shares
”) which shall be issued at the Closing in proportion to the
principal amount of Notes purchased at the Closing.
C.
Contemporaneously with the execution
and delivery of this Agreement, the Company and Hesperion
US, Inc., a Maryland corporation (“ Hesperion US
”), are executing and delivering an Amendment No. 2 to
Security Agreement, in the form attached as Exhibit B
(as the same may be amended, supplemented, restated or modified and
in effect from time to time, the “ Security Agreement
”), in favor of the Collateral Agent (as defined in the
Security Agreement), for the benefit of the Buyers, pursuant to
which the Company and Hesperion US will agree to provide the
Collateral Agent, as agent for the Buyers, with security interests
in substantially all of the material assets of the Company and
Hesperion US.
D.
Contemporaneously with the Closing,
Hesperion US will execute and deliver an Amendment No. 1 to
Guaranty, in the form attached hereto as Exhibit C (as
the same may be amended, supplemented, restated or modified and in
effect from time to time, the “ Guaranty ”),
pursuant to which Hesperion US will agree to guaranty certain
obligations of the Company (the guarantees under the Guaranty,
including any such guarantees added after the Closing, being
referred to herein as the “ Guarantees
”).
NOW THEREFORE
, the Company and each of the
Buyers, severally and not jointly, hereby agree as
follows:
1.
PURCHASE AND
SALE OF NOTES AND SHARES .
a.
Purchase and
Sale of Notes and Shares . Subject to the
satisfaction (or waiver) of the conditions set forth in Sections
7 and 8 below, the Company shall issue and sell to each
Buyer and each Buyer severally agrees to purchase from the Company
the Notes. On the Closing Date, each Buyer shall purchase
(a) Notes in the respective principal amounts set forth
opposite such Buyer’s name on the Schedule of Buyers ,
which Notes shall be issued to the Buyers on the Closing Date; and
(b) the number of Shares next to such Buyer’s name on
the Schedule of Buyers , which shall be issued to such Buyer
on the Closing Date. The purchase price (the “
Purchase Price ”) for the Notes and
the related Shares purchased by each Buyer shall be as set forth
opposite such Buyer’s name on the Schedule of Buyers
(representing an aggregate purchase price of $2,000,000 for the
Notes and Shares to be purchased by the Buyers at the
Closing).
b.
Closing
Date . The date and time of
the closing (the “Closing ”) shall be
10:00 a.m., New York City time, on the date that is one
(1) day after the satisfaction (or waiver) of all of the
conditions to the Closing set forth in Sections 7 and
8 (or such later or earlier date as is mutually agreed to by
the Company and the Buyers) (the “Closing Date” ). The Closing shall
occur at the offices of Akerman Senterfitt, One Southeast Third
Avenue, 25 th Floor, Miami, FL 33131,
or at such other place as the Company and Buyers may collectively
designate in writing.
For purposes of this Agreement, each
Buyer’s “ Allocation Percentage” shall be
with respect to all Notes purchased pursuant to this Agreement, the
quotient of (a) the total original aggregate principal
amount of all Notes purchased by such Buyer pursuant to this
Agreement, divided by (b) the total original aggregate
principal amount of all Notes purchased pursuant to this
Agreement.
c.
Form of
Payment and Delivery of Shares . On the Closing Date,
(i) each Buyer shall pay to the Company an amount equal to the
principal amount of the Notes such Buyer is to purchase as of the
Closing Date, by wire transfer of immediately available funds in
accordance with the Company’s written wire instructions (less
any amount deducted and paid in accordance with
Section 4(h) ), and (ii) the Company shall deliver
(or cause its transfer agent to deliver) to each Buyer (i) a
Note (or Notes in the principal amounts as such Buyer shall
request) representing the original principal amount of the Notes
that such Buyer is purchasing hereunder on the Closing Date, and
(ii) Share Certificates for the Shares to be issued to such
Buyer on the Closing Date as provided on the Schedule of
Buyers , in each case duly executed on behalf of the Company
and registered in the name of such Buyer or its
designee.
d.
Fractional
Shares . No fractional shares
of Common Stock are to be issued pursuant to this
Section 1 , but rather the number of shares of Common
Stock to be issued pursuant to this Section 1 shall be
rounded up to the nearest whole number.
e.
Currency;
Interest . All payments to a
Buyer under this Agreement or any of the other Transaction
Documents shall be made in lawful money of the United States
of
2
America, by wire transfer of
immediately available funds to such accounts as such Buyer may from
time to time designate by written notice in accordance with
Section 10(f) of this Agreement. All
references herein and in each of the other Transaction Documents to
“dollars” or “$” shall mean the lawful
money of the United States of America. Any amounts payable
pursuant to this Agreement that are not paid when due, after the
expiration of all notice and cure periods set forth herein, shall
bear interest at the rate equal to the lesser of (i) 2.0% per
month, prorated for partial months, and (ii) the highest
lawful interest rate.
2.
BUYER’S
REPRESENTATIONS AND WARRANTIES .
Each Buyer represents and warrants,
as of the date of this Agreement and as of the Closing Date, with
respect to only itself, that:
a.
Investment
Purpose . Such Buyer is
acquiring the Notes (together with the related Guarantees) and the
Shares purchased by such Buyer hereunder (the Notes, the Guarantees
and the Shares being collectively referred to herein as the
“ Securities
”), for
such Buyer’s own account and not with a view towards, or for
resale in connection with, the public sale or distribution thereof,
except pursuant to sales registered under, or exempted from the
registration requirements of, the 1933 Act; provided ,
however , that by making the representations herein, such
Buyer does not agree to hold any of the Securities for any minimum
or other specific term and reserves the right to dispose of the
Securities at any time in accordance with or pursuant to a
registration statement or an exemption under the
1933 Act.
b.
Accredited
Investor Status . Such Buyer is an
“accredited investor” as that term is defined in
Rule 501(a) of Regulation D.
c.
Reliance on
Exemptions . Such Buyer
understands that the Securities are being offered and sold to it in
reliance on specific exemptions from the registration requirements
of the Securities Laws and that the Company is relying in part upon
the truth and accuracy of, and such Buyer’s compliance with,
the representations, warranties, agreements, acknowledgments and
understandings of such Buyer set forth herein in order to determine
the availability of such exemptions and the eligibility of such
Buyer to acquire the Securities.
d.
Information
. Such
Buyer and its advisors, if any, have been furnished with all
materials relating to the business, finances and operations of the
Company and materials relating to the offer and sale of the
Securities that have been requested by such Buyer. Such Buyer
and its advisors, if any, have been afforded the opportunity to ask
questions of the Company. Neither such inquiries nor any
other due diligence investigations conducted by such Buyer or its
advisors, if any, or its representatives shall modify, amend or
affect such Buyer’s right to rely on the Company’s
representations and warranties contained in Sections 3 and
11(l) below or contained in any of the other
Transaction Documents. Such Buyer understands that its
investment in the Securities involves a high degree of risk and
that it has reviewed the Company’s SEC Documents and the
disclosures contained therein, including, without limitation, that
set forth under the heading “Risk Factors.” Such
Buyer has sought such accounting, legal and tax advice as it has
considered necessary to make an informed investment decision with
respect to its acquisition of the Securities.
3
e.
No
Governmental Review . Such Buyer
understands that no Governmental Entity has passed on or made any
recommendation or endorsement of the Securities or the fairness or
suitability of an investment in the Securities nor have such
authorities passed upon or endorsed the merits of the offering of
the Securities.
f.
Transfer or
Resale . Such Buyer
understands that: (i) the Securities have not been and are not
being registered under the 1933 Act or any other Securities Laws,
and may not be offered for sale, sold, assigned or transferred
unless (A) subsequently registered thereunder, (B) such
Buyer shall have delivered to the Company an opinion of counsel, in
a generally acceptable form, to the effect that the Securities to
be sold, assigned or transferred may be sold, assigned or
transferred pursuant to an exemption from such registration, or
(C) such Buyer provides the Company with reasonable assurance
that the Securities can be sold, assigned or transferred pursuant
to Rule 144 promulgated under the 1933 Act, as amended (or a
successor rule thereto) (“ Rule 144 ”); (ii) any sale
of the Securities made in reliance on Rule 144 may be made
only in accordance with the terms of Rule 144, and further, if
Rule 144 is not applicable, any resale of the Securities under
circumstances in which the seller (or the Person through whom the
sale is made) may be deemed to be an underwriter (as that term is
defined in the 1933 Act) may require compliance with some other
exemption under the 1933 Act or any other Securities Laws; and
(iii) neither the Company nor any other person is under any
obligation to register the Securities under the 1933 Act or any
other Securities Laws. Notwithstanding the foregoing
provisions of this paragraph, the Securities may be pledged in
connection with a bona fide margin account or other loan or
financing arrangement secured by the Securities.
g.
Legends
. Such
Buyer understands that, except as set forth below, the Share
Certificates and the certificates or other instruments representing
the Notes shall bear a restrictive legend in the following form
(the “ 1933 Act
Legend ”) (and a stop-transfer
order may be placed against transfer of such Share
Certificates):
THE SECURITIES REPRESENTED BY THIS
CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE
SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR
ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE
REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT
OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS OR
(B) AN OPINION OF COUNSEL, IN A GENERALLY ACCEPTABLE FORM,
THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR APPLICABLE
STATE SECURITIES LAWS OR (II) UNLESS SOLD PURSUANT TO
RULE 144 UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE
SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE
MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY
THE SECURITIES.
The legend set forth above shall be removed and
the Company shall issue a certificate without such legend to the
holder of the Securities, if (i) such Securities are
registered for resale under the 1933 Act, (ii) such holder
provides the Company with reasonable assurances that the Securities
can be sold without restriction pursuant to Rule 144
promulgated under the 1933 Act
4
(or a successor rule thereto), or
(iii) such holder provides the Company reasonable assurances
that the Securities have been or are being sold pursuant to
Rule 144.
h.
Authorization;
Enforcement; Validity . Such Buyer is a
validly existing corporation, partnership, limited liability
company or other entity and has the requisite corporate,
partnership, limited liability or other organizational power and
authority to purchase the Securities pursuant to this
Agreement. This Agreement has been duly and validly
authorized, executed and delivered on behalf of such Buyer and is a
valid and binding agreement of such Buyer enforceable against such
Buyer in accordance with its terms. The Security Agreement
and each of the other agreements entered into by such Buyer in
connection with the transactions contemplated hereby as of the
Closing will have been duly and validly authorized, executed and
delivered on behalf of such Buyer as of the Closing and will be
valid and binding agreements of such Buyer, enforceable against
such Buyer in accordance with their respective terms.
i.
Residency
. Such
Buyer is a resident of that jurisdiction specified below its
address on the Schedule of Buyers .
j.
No Other
Agreements . As of the Closing
Date, such Buyer has not, directly or indirectly, made any
agreements with the Company relating to the terms or conditions of
the transactions contemplated by the Transaction Documents except
as set forth in the Transaction Documents.
3.
REPRESENTATIONS AND
WARRANTIES OF THE COMPANY .
The Company represents and warrants,
as of the date of this Agreement as of the Closing Date, to each
Buyer, that except as set forth in the Schedules to this Agreement
delivered by the Company to Buyer:
a.
Organization
and Qualification; Subsidiaries . The Company was
formed on April 22, 2002. Set forth in Schedule
3(a) is a true and correct list of the Company’s
Subsidiaries and Foreign Subsidiaries and the jurisdiction in which
each is organized or incorporated, together with their respective
jurisdictions of organization. Other than with respect to the
entities listed on Schedule 3(a) , the Company does not
directly own any security or beneficial ownership interest in any
other Person (including through joint venture or partnership
agreements) or have any interest in any other Person. Each of
the Company and its Subsidiaries and, to the Company’s
Knowledge, Foreign Subsidiaries is a corporation, limited liability
company, partnership or other entity and is duly organized or
formed and validly existing in good standing under the laws of the
jurisdiction in which it is incorporated or organized (other than
the Subsidiary) and has the requisite corporate, partnership,
limited liability company or other organizational power and
authority to own its properties and to carry on its business as now
being conducted and as proposed to be conducted by the Company and
its Subsidiaries and, to the Company’s Knowledge, its Foreign
Subsidiaries. Each of the Company and its Subsidiaries, and,
to the Company’s Knowledge, its Foreign Subsidiaries is duly
qualified to do business and is in good standing in every
jurisdiction in which its ownership of property or the nature of
the business conducted or proposed to be conducted by the Company
and its Subsidiaries, and, to the Company’s Knowledge, its
Foreign Subsidiaries will make such qualification necessary, except
to the extent that the failure to be so qualified or be in good
standing could not have and could
5
not be, individually or in
the aggregate, reasonably be expected to have a Material Adverse
Effect. Except as set forth in Schedule 3(a) , the
Company holds all right, title and interest in and to 100% of the
capital stock, equity or similar interests of each of its
Subsidiaries, and, to the Company’s Knowledge and to the
extent applicable, its Foreign Subsidiaries free and clear of any
Liens (as defined below), including any restriction on the use,
voting, transfer, receipt of income or other exercise of any
attributes of free and clear ownership by a current holder, and no
such Subsidiary or, to the Company’s Knowledge, Foreign
Subsidiary owns capital stock or holds an equity or similar
interest in any other Person.
b.
Authorization;
Enforcement; Validity . Each of the Company
and its Subsidiaries has the requisite corporate or other
organizational power and authority to enter into and perform its
obligations under this Agreement and each of the other Transaction
Documents to which such Person is a party and to issue the
Securities in accordance with the terms hereof and thereof.
The execution and delivery of the Transaction Documents by the
Company and each of its Subsidiaries and the consummation by the
Company and each of its Subsidiaries of the transactions
contemplated hereby and thereby, including the issuance of the
Notes, the Guarantees and the Shares to be issued at the Closing,
have been duly authorized by the respective boards of directors (or
a committee thereof), members, managers, trustees, stockholders,
other equityholders or holders of beneficial interests, as
applicable, of the Company and each of its Subsidiaries and no
further consent or authorization is required by the Company, any of
its Subsidiaries or any of their respective boards of directors,
members, managers, trustees, stockholders, other equityholders or
holders of beneficial interests, as applicable. This
Agreement and the other Transaction Documents dated of even date
herewith have been duly executed and delivered by the Company and
each of its Subsidiaries that is a party thereto, and constitute
the valid and binding obligations of the Company and each of its
Subsidiaries, enforceable against the Company and each of its
Subsidiaries in accordance with their respective terms, except as
may be limited by bankruptcy, insolvency, fraudulent conveyance or
similar laws affecting creditors’ rights generally and
general principles of equity. As of the Closing, the
Transaction Documents dated after the date of this Agreement shall
have been duly executed and delivered by the Company and each of
its Subsidiaries that is a party thereto and shall constitute the
valid and binding obligations of the Company and each of its
Subsidiaries, enforceable against the Company and each of its
Subsidiaries in accordance with their respective terms, except as
may be limited by bankruptcy, insolvency, fraudulent conveyance or
similar laws affecting creditors’ rights generally and
general principles of equity.
c.
Capitalization
. The
authorized Capital Stock of the Company consists of
750,000,000 shares of Common Stock, of which:
(i)
625,632,455
shares are issued and outstanding; provided , however
, that as of the Closing Date;
(ii)
100,000,000
shares are reserved for issuance pursuant to the Company’s
stock option, restricted stock and employee stock purchase plans
described in the SEC Documents (the “ Equity Plans ”), including
71,510,000 shares issuable pursuant to outstanding awards under the
Equity Plans;
6
(iii)
3,290,666 shares
are reserved for issuance pursuant to the Company’s
outstanding warrants described on Schedule 3(c)(iii)
(the “ Warrants ”); and
(iv)
4,285,714 shares
of Common Stock are reserved for issuance to Millennix, Inc.
on January 1, 2009 (subject to Gene Resnick remaining an
employee through such issuance date) pursuant to that certain Asset
Purchase Agreement dated November 9, 2005 (as amended on
September 6, 2006), related to the purchase of the assets of
Millennix, Inc.
No shares of Common Stock are reserved for
issuance under any plan, agreement or arrangement, other than
shares of Common Stock reserved for issuance with respect to the
Warrants and under the Equity Plans; and except as described in the
foregoing provisions of this Section 3(c) , there are
no shares of Capital Stock, Options, Convertible Securities or
other equity securities of the Company authorized, issued or
outstanding, and the Company is not under any current or future
obligation to issue any such shares of Capital Stock, Options,
Convertible Securities or other equity securities of the
Company. All of the outstanding and issuable shares of
Capital Stock have been, or upon issuance will be, validly issued
and are, or upon issuance will be, fully paid and
nonassessable.
Except as set forth on Schedule 3(c)
:
(1)
except as set forth in the
Securities Purchase Agreement, dated as of October 31, 2007,
as amended, among the Company and the investors listed on the
Schedule of Buyers attached thereto, no shares of the Capital Stock
of the Company or any of its Subsidiaries are subject to preemptive
rights or any other similar rights or any Liens suffered or
permitted by the Company or any of its Subsidiaries;
(2)
there are no outstanding options,
warrants, scrip, rights to subscribe to, calls or commitments of
any character whatsoever relating to, or securities or rights
convertible into or exercisable for, any shares of Capital Stock of
the Company or any of its Subsidiaries or, to the Company’s
Knowledge, any of its Foreign Subsidiaries, or contracts,
commitments, understandings or arrangements by which the Company or
any of its Subsidiaries or, to the Company’s Knowledge, any
of its Foreign Subsidiaries is or may become bound to issue
additional shares of Capital Stock of the Company or any of its
Subsidiaries or Foreign Subsidiaries or options, warrants, scrip,
rights to subscribe to, calls or commitments of any character
whatsoever relating to, or securities or rights convertible into or
exercisable for, any shares of Capital Stock of the Company or any
of its Subsidiaries or Foreign Subsidiaries;
(3)
to the Knowledge of the Company,
there are no voting trusts, proxies or other agreements,
commitments or understandings of any character with respect to the
voting of any shares of Capital Stock of the Company or any of its
Subsidiaries or Foreign Subsidiaries, and there are no agreements
or arrangements under which the Company or any of its Subsidiaries
or Foreign Subsidiaries is obligated to register the sale of any of
their securities under the 1933 Act (except the registration rights
set forth in the Company’s SEC Documents, including
registration rights agreements entered dated July 31, 2006 and
November 9, 2005 and the registration rights
7
given to the investors in the
Company’s October 17, 2006 financing or such other
rights as shall have been waived or terminated prior to the
Closing);
(4)
other than the Notes and the Prior
Notes, there are no outstanding securities or instruments of the
Company or any of its Subsidiaries or, to the Company’s
Knowledge, any of its Foreign Subsidiaries that contain any
redemption or similar provisions, and there are no contracts,
commitments, understandings or arrangements by which the Company or
any of its Subsidiaries or, to the Company’s Knowledge, any
of its Foreign Subsidiaries is or may become bound to redeem a
security of the Company or any of its Subsidiaries or Foreign
Subsidiaries, and there are no other stockholder agreements or
similar agreements to which the Company, any of its Subsidiaries
or, to the Company’s Knowledge, any Foreign Subsidiary or any
holder of the Company’s Capital Stock is a party;
(5)
there are no securities or
instruments containing anti-dilution or similar provisions that
will or may be triggered by the issuance of the
Securities;
(6)
the Company does not have any
stock appreciation rights or “phantom stock” plans or
agreements or any similar plan or agreement; and
(7)
to the Company’s Knowledge,
no officer or director of the Company or beneficial owner of any of
the Company’s outstanding Common Stock has pledged Common
Stock in connection with a margin account or other loan secured by
such Common Stock.
The Company has furnished to each
Buyer true and correct copies of:
(X)
The Company’s Certificate of
Incorporation, as amended and in effect (the “ Certificate
of Incorporation ”); and
(Y)
The Company’s Bylaws, as
amended and in effect (the “ Bylaws
”).
All of the equity interests of each
of the Subsidiaries are certificated or otherwise represented in
tangible form.
d.
Issuance of
Securities . The Notes are duly
authorized and, upon issuance in accordance with the terms of this
Agreement, shall be free from all taxes and Liens with respect to
the issuance thereof and entitled to the rights set forth
therein. The Shares are duly authorized and, upon issuance in
accordance with the terms of this Agreement, will be validly
issued, fully paid and nonassessable and free from taxes and Liens
with respect to the issuance thereof, with the holders being
entitled to all rights accorded to a holder of Common Stock.
The issuance by the Company of the Securities is exempt from
registration under the 1933 Act and any other applicable Securities
Laws.
e.
No
Conflicts . Except as set forth
on Schedule 3(e) , the execution and delivery of this
Agreement and the other Transaction Documents by the Company and
each of its Subsidiaries, the performance by the Company and each
of its Subsidiaries of its obligations hereunder and thereunder and
the consummation by the Company and each of its Subsidiaries
of
8
the transactions
contemplated hereby and thereby (including the reservation for
issuance and the issuance of the Shares) will not:
(i)
result in a
violation of the certificate or articles of incorporation,
certificate or articles of organization, bylaws, operating
agreement, partnership agreement or any other governing documents,
as applicable, of any such Person;
(ii)
conflict with, or
constitute a breach or default (or an event which, with the giving
of notice or passage of time or both, constitutes or would
constitute a breach or default) under, or give to others any right
of termination, amendment, acceleration or cancellation of, or
other remedy with respect to, any agreement, indenture, instrument
or other document to which any such Person is a party or by which
such Person is bound; or
(iii)
result in a
violation of any Law, rule, regulation, order, judgment or decree
(including Securities Laws and the rules and regulations, if
any, of the Principal Market) applicable to any such Person or by
which any property or asset of any such Person is bound or
affected.
Neither the Company nor any of its Subsidiaries
nor, to the Company’s Knowledge, any of its Foreign
Subsidiaries is in violation of any term of its certificate or
articles of incorporation, certificate or articles of organization,
bylaws, operating agreement, partnership agreement or any other
governing document, as applicable. Neither the Company nor
any of its Subsidiaries nor, to the Company’s Knowledge, any
of its Foreign Subsidiaries is or has been in violation of any term
of or in default under (or with the giving of notice or passage of
time or both would be in violation of or default under) any
contract, agreement, mortgage, indebtedness, indenture, instrument,
document, judgment, decree or order or any Law applicable to the
Company or its Subsidiaries or Foreign Subsidiaries, except where
such violation or default could not, individually or in the
aggregate, reasonably be expected to have a Material Adverse Effect
or to result in the acceleration of any Indebtedness or other
obligation. The business of the Company and its Subsidiaries
and, to the Company’s Knowledge, its Foreign Subsidiaries has
not been and is not being conducted in violation of any Law of any
Governmental Entity except as could not, individually or in the
aggregate, reasonably be expected to have a Material Adverse
Effect. Except for the filing of instruments to perfect
security interests and as set forth in Schedule 3(e) ,
neither the Company nor any of its Subsidiaries is, has been, or
will be required to obtain any consent, authorization or order of,
or make any filing or registration with, any court or Governmental
Entity in order for it to execute, deliver or perform any of its
obligations under or contemplated by the Transaction Documents in
accordance with the terms hereof or thereof. All consents,
authorizations, orders, filings and registrations that the Company
or any of its Subsidiaries is or has been required to obtain as
described in the preceding sentence have been obtained or effected
on or prior to the date of this Agreement and prior to the date of
the effectiveness of such requirement.
f.
SEC Documents;
Financial Statements .
(i)
Except as set
forth on Schedule 3(f) , since December 31, 2007, the
Company has filed all reports, schedules, forms, statements and
other documents required
9
to be filed by it
with the SEC pursuant to the reporting requirements of the 1934 Act
(all of the foregoing filed prior to the date this representation
is made (including all exhibits included therein and financial
statements and schedules thereto and documents incorporated by
reference therein) being referred to herein as the “
SEC Documents ” and the
Company’s consolidated balance sheet as of March 31,
2008, as included in the Company’s quarterly report on
Form 10-Q for the period then ended, as filed with the SEC on
May 15, 2008, being referred to herein as the “
Most Recent Balance Sheet
”).
Each of the SEC Documents was filed with the SEC via the
SEC’s EDGAR system within the time frames prescribed by the
SEC for the filing of such SEC Documents such that each filing was
timely filed with the SEC (with giving effect to any extensions of
time permitted by Rule 12b-25 under the 1934 Act). As of
their respective dates, the SEC Documents complied in all material
respects with the Securities Laws. None of the SEC Documents,
at the time they were filed with the SEC, contained any untrue
statement of a material fact or omitted to state a material fact
required to be stated therein or necessary in order to make the
statements therein, in light of the circumstances under which they
were made, not misleading. Since the filing of each of the
SEC Documents, no event has occurred that would require an
amendment or supplement to any such SEC Document and as to which
such an amendment or supplement has not been filed and made
publicly available on the SEC’s EDGAR system no less than
five (5) Business Days prior to the date this representation
is made. Except as set forth on Schedule 3(f)(i) , the
Company has not received any written comments from the SEC staff
that have not been resolved to the satisfaction of the SEC
staff.
(ii)
As of their
respective dates, the consolidated financial statements of the
Company and its Subsidiaries and Foreign Subsidiaries
included in the SEC Documents complied as to form in all material
respects with applicable accounting requirements and the Securities
Laws with respect thereto. Such consolidated financial
statements have been prepared in accordance with GAAP, consistently
applied, during the periods involved (except (i) as may be
otherwise indicated in such financial statements or the notes
thereto, or (ii) in the case of unaudited interim statements,
to the extent they may exclude footnotes) and fairly present in all
material respects the financial position of the Company and its
Subsidiaries and Foreign Subsidiaries as of the dates thereof and
the results of their operations and cash flows for the periods then
ended in accordance with GAAP (subject, in the case of unaudited
statements, to normal year-end audit adjustments that are not
material individually or in the aggregate).
(iii)
Since
December 31, 2007, none of the Company, its Subsidiaries and
their respective officers, directors and Affiliates or, to the
Company’s Knowledge, any stockholder of the Company has made
any filing with the SEC or issued any press release on behalf of
the Company or any of its Subsidiaries or otherwise relating to the
Company or any of its Subsidiaries that contains any untrue
statement of a material fact or omits any statement of material
fact necessary in order to make the statements therein, in the
light of the circumstances under which they are or were made, not
misleading or has provided any other information to any Buyer,
including information referred to in Section 2(d) ,
that, considered in the aggregate, contains any untrue statement of
a material fact or omits to state any material fact necessary in
order to make the statements
10
therein, in the
light of the circumstances under which they are or were made, not
misleading.
(iv)
Except as set
forth in Schedule 3(f)(iv) , the Company is not required to
file and will not be required to file any agreement, note, lease,
mortgage, deed or other instrument entered into prior to the date
this representation is made and in effect on the date this
representation is made and to which the Company or any Subsidiary
or, to the Company’s Knowledge, any Foreign Subsidiary is a
party or by which the Company or any Subsidiary or Foreign
Subsidiary is bound that has not been previously filed as an
exhibit (including by way of incorporation by reference) to its
reports filed or made with the SEC under the 1934 Act.
(v)
The accounting
firm that has expressed its opinion with respect to the
consolidated financial statements included in the Company’s
most recently filed annual report on Form 10-KSB (the
“ Audit Opinion
”) is
independent of the Company pursuant to the standards set forth in
Rule 2-01 of Regulation S-X promulgated by the SEC and such
firm was otherwise qualified to render the Audit Opinion under
applicable Securities Laws. Each accounting firm that since
such filing has conducted or will conduct a review or audit of any
of the Company’s consolidated financial statements is
independent of the Company pursuant to the standards set forth in
Rule 2-01 of Regulation S-X promulgated by the SEC and is
otherwise qualified to conduct such review or audit and render an
audit opinion under applicable Securities Laws.
(vi)
There is no
transaction, arrangement or other relationship between the Company
and an unconsolidated or other off-balance-sheet entity that is
required to be disclosed by the Company in its reports pursuant to
the 1934 Act that has not been so disclosed in the SEC Documents at
least five (5) Business Days prior to the date of this
Agreement.
(vii)
Since
December 31, 2007, there have been no internal or SEC
inquiries or investigations (formal or informal) regarding
accounting or revenue recognition discussed with, reviewed by or
initiated at the direction of any executive officer, board of
directors or any committee thereof of the Company or any of its
Subsidiaries or, to the Company’s Knowledge, Foreign
Subsidiaries.
(viii)
The Company is
not a “shell company” (as defined in Rule 12b-2
under the 1934 Act).
g.
Sarbanes-Oxley
Compliance; Internal Accounting Controls; Disclosure Controls and
Procedures; Books and Records .
(i)
Except for as set
forth in the SEC Documents, the Company and its Subsidiaries and,
to the Company’s Knowledge, its Foreign Subsidiaries are in
all material respects in compliance with the applicable provisions
of the Sarbanes-Oxley Act of 2002, as amended, and the
rules and regulations thereunder (collectively, “
Sarbanes-Oxley ”).
11
(ii)
Since
December 31, 2007, neither the Company nor any of its
Subsidiaries or, to the Company’s Knowledge, its Foreign
Subsidiaries nor any director or officer of the Company or any of
its Subsidiaries or, to the Company’s Knowledge, its Foreign
Subsidiaries has received or otherwise had or obtained Knowledge of
any complaint, allegation, assertion or claim, whether written or
oral, regarding the accounting or auditing practices, procedures,
methodologies or methods of the Company or any of its Subsidiaries
or Foreign Subsidiaries or its internal accounting controls,
including any complaint, allegation, assertion or claim that the
Company or any of its Subsidiaries or Foreign Subsidiaries has
engaged in questionable accounting or auditing
practices.
(iii)
No attorney
representing the Company or any of its Subsidiaries, whether or not
employed by the Company or any of its Subsidiaries, has reported
evidence of a material violation of Securities Laws, breach of
fiduciary duty or similar violation by the Company or any of its
Subsidiaries or any of their respective officers, directors,
employees or agents to their respective boards of directors or any
committee thereof or pursuant to Section 307 of
Sarbanes-Oxley.
(iv)
Except as set
forth on Schedule 3(g) and in the SEC Documents, the
Company has, and has caused each of its Subsidiaries and, to the
Company’s Knowledge, its Foreign Subsidiaries, if applicable,
to, at all times keep books, records and accounts with respect to
all of such Person’s business activities, in accordance with
sound accounting practices and GAAP, or with respect to the Foreign
Subsidiaries, the applicable accounting standards, consistently
applied. Except as set forth in the SEC Documents, the
Company and each of its Subsidiaries and, to the Company’s
Knowledge, its Foreign Subsidiaries, if applicable, maintains a
system of internal accounting controls sufficient to provide
reasonable assurance that (A) transactions are executed in
accordance with management’s general or specific
authorizations, (B) transactions are recorded as necessary to
permit preparation of financial statements in conformity with
generally accepted accounting principles and to maintain asset and
liability accountability, (C) access to assets or incurrence
of liability is permitted only in accordance with
management’s general or specific authorization and
(D) the recorded accountability for assets and liabilities is
compared with the existing assets and liabilities at reasonable
intervals and appropriate action is taken with respect to any
differences.
(v)
The Company has
timely filed and made publicly available on the SEC’s EDGAR
system no less than five (5) Business Days prior to the date
of this representation, all certifications and statements required
by (A) Rule 13a-14 or Rule 15d-14 under the 1934 Act
and (B) Section 906 of Sarbanes-Oxley with respect to any
Company SEC Documents.
(vi)
Except as set
forth in the SEC Documents, the Company maintains disclosure
controls and procedures required by Rule 13a-15 or
Rule 15d-15 under the 1934 Act. Except as set forth
in the SEC Documents, such disclosure controls and procedures are
effective to ensure that the information required to be disclosed
by the Company in the reports that it files with or submits to the
SEC (A) is recorded, processed, summarized and reported
accurately within the time periods specified in the SEC’s
rules
12
and forms and
(B) is accumulated and communicated to the Company’s
management, including its principal executive officer and principal
financial officer, as appropriate to allow timely decisions
regarding required disclosure.
(vii)
Except as set
forth on Schedule 3(g) and in the SEC Documents, the
Company maintains internal control over financial reporting
required by Rule 13a-14 or Rule 15d-14 under the
1934 Act. As set forth in the SEC Documents, prior to
January 1, 2008, such internal control over financial
reporting contained material weaknesses.
h.
Absence of
Certain Changes . Since
December 31, 2007, neither the Company nor any of its
Subsidiaries or, to the Company’s Knowledge, Foreign
Subsidiaries has taken any steps, and neither the Company nor any
of its Subsidiaries or, to the Company’s Knowledge, Foreign
Subsidiaries currently expects to take any steps to seek protection
pursuant to any bankruptcy law nor does the Company or any of its
Subsidiaries or Foreign Subsidiaries, to the Company’s
Knowledge, have any Knowledge or reason to believe that the
creditors of such Person intend to initiate involuntary bankruptcy
proceedings or any knowledge of any fact that would reasonably lead
a creditor to do so. Neither the Company nor any of its
Subsidiaries or, to the Company’s Knowledge, any Foreign
Subsidiary is as of the date this representation is made, nor after
giving effect to the transactions contemplated hereby or by any of
the other Transaction Documents will be, Insolvent. Except as
set forth in the SEC Documents, since December 31, 2007,
neither the Company nor any of its Subsidiaries or, to the
Company’s Knowledge, any of its Foreign Subsidiaries has
declared or paid any dividends or sold any assets outside of the
ordinary course of business. Except as set forth in the SEC
Documents, since December 31, 2007, neither the Company nor
any of its Subsidiaries has had any capital expenditures outside
the ordinary course of its business.
i.
Absence of
Litigation . Except as set
forth on Schedule 3(i) , (i) there has at no time been
any action, suit, proceeding, inquiry or investigation
(“ Litigation
”) before
or by any court, public board, Governmental Entity, self-regulatory
organization or body pending or, to the Company’s Knowledge,
threatened against or affecting the Company or any of its
Subsidiaries or Foreign Subsidiaries or any of their assets, and
(ii) to the Company’s Knowledge, no director or officer
of the Company or any of its Subsidiaries or Foreign Subsidiaries
has been involved in securities-related Litigation during the past
five (5) years. No Litigation disclosed on Schedule
3(i) has had or could reasonably be expected to have,
individually or in the aggregate, a Material Adverse
Effect.
j.
Full
Disclosure; No Undisclosed Events, Liabilities, Developments or
Circumstances . Since
December 31, 2007, there has been no Material Adverse Effect
and no circumstances exist that, individually or in the aggregate,
could reasonably be expected to be, cause or have a Material
Adverse Effect. Except (A) as and to the extent
disclosed or reserved against on the Most Recent Balance Sheet,
(B) as incurred since the date thereof in the ordinary course
of business consistent with past practice, (C) as incurred at
the Closing Date under the Notes and the other Transaction
Documents, or (D) as set forth on Schedule 3(j) ,
neither the Company, nor any of its Subsidiaries or, to the
Company’s Knowledge, any of its Foreign Subsidiaries has any
material liabilities or obligations of any nature, whether fixed or
unfixed, known or unknown, secured or unsecured, absolute, accrued,
contingent or otherwise and whether due or to become due. No
representation or warranty or other statement made by
the
13
Company in this Agreement or
any of the other Transaction Documents, the Schedules hereto or any
certificate or instrument delivered pursuant to this Agreement
contains any untrue statement or omits to state a material fact
necessary to make any such statement, in light of the circumstances
in which it was made, not misleading.
k.
Acknowledgment
Regarding Buyers’ Purchase of Notes and Shares
. The
Company acknowledges and agrees that each Buyer is acting solely in
the capacity of an arm’s length purchaser with respect to the
Company in connection with this Agreement and the other Transaction
Documents and the transactions contemplated hereby and
thereby. The Company further acknowledges that no Buyer is
acting as a financial advisor or fiduciary of any party to this
Agreement or any of the other Transaction Documents (or in any
similar capacity) with respect to this Agreement and the other
Transaction Documents and the transactions contemplated hereby and
thereby, and any advice given by any Buyer or any of its
representatives or agents in connection with the Transaction
Documents and the transactions contemplated hereby and thereby is
merely incidental to such Buyer’s purchase of the
Securities. The Company further represents to each Buyer that
the decision of the Company and each of its Subsidiaries to enter
into the Transaction Documents has been based solely on the
independent evaluation by such Person and its
representatives.
l.
No General
Solicitation . Neither the Company
nor any of its Affiliates, nor any Person acting on the behalf of
any of the foregoing, has engaged or will engage in any form of
general solicitation or general advertising (within the meaning of
Regulation D under the 1933 Act), including advertisements,
articles, notices, or other communications published in any
newspaper, magazine or similar media or broadcast over radio,
television or internet or any seminar or meeting whose attendees
have been invited by general solicitation or general advertising,
in connection with the offer or sale of the Securities.
m.
No
Registration . Neither the Company
nor any of its Affiliates, nor any Person acting on the behalf of
any of the foregoing, has, directly or indirectly, made any offers
or sales of any security or solicited any offers to purchase any
security, under circumstances that would require registration of
any of the Securities under the 1933 Act.
n.
Employee
Relations . Except as set forth
on Schedule 3(n) , neither the Company nor any of its
Subsidiaries, nor, to the Company’s Knowledge, any of its
Foreign Subsidiaries is involved in any labor union dispute nor, to
the Knowledge of the Company, is any such dispute threatened.
To the Knowledge of the Company, none of the employees of either
the Company or any of its Subsidiaries or Foreign Subsidiaries is
or has been a member of a union that relates, or following the
Closing will relate, to such employee’s relationship with the
Company and neither the Company nor any of its Subsidiaries or, to
the Company’s Knowledge, any of its Foreign Subsidiaries is
or following the Closing will be, a party to a collective
bargaining agreement. No executive officer (as defined in
Rule 3b-7 under the 1934 Act), nor any other individual whose
termination would be required to be disclosed on a Current Report
on Form 8-K, has notified the Company that such individual
intends to leave the Company or otherwise terminate such
individual’s employment with the Company. Such
individuals constitute all of the employees necessary to conduct
the Company’s business as presently conducted and as proposed
to be conducted (as described to Buyers prior to the date
hereof). Except as set forth on Schedule 3(n) , to the
Knowledge of the Company no such individual is,
14
has been, or is now expected
to be, in violation of any material term of any employment
contract, confidentiality, disclosure or proprietary information
agreement or non-competition agreement, or any other contract or
agreement or any restrictive covenant, and the employment of each
such individual does not, has not and will not subject the Company
or any of its Subsidiaries, or, to the Company’s Knowledge,
any of its Foreign Subsidiaries to any liability with respect to
any of the foregoing matters that would, individually or in the
aggregate, have a Material Adverse Effect. Except as set
forth in Schedule 3(n) , to the Company’s Knowledge
the Company and each of its Subsidiaries and, to the
Company’s Knowledge, each of its Foreign Subsidiaries, as
applicable, is in compliance in all material respects with all Laws
relating to employment and employment practices, terms and
conditions of employment and wages and hours. Except as set
forth in Schedule 3(n) , the Company and each of its
Subsidiaries and, to the Company’s Knowledge, each of its
Foreign Subsidiaries, as applicable, is in compliance in all
material respects with all Laws relating to employee benefits and
employee benefit plans (as such terms are defined in
ERISA).
o.
Intellectual
Property Rights . Except as set forth
on Schedule 3(o) , the Company and its Subsidiaries and, to
the Company’s Knowledge, its Foreign Subsidiaries, if
applicable, own or possess adequate rights or licenses to use all
trademarks, trademark applications and registrations, trade names,
service marks, service mark registrations, service names, patents,
patent rights, patent applications, copyrights (whether or not
registered), inventions, licenses, approvals, governmental
authorizations, trade secrets and other intellectual property
rights (collectively, “ Intellectual Property ”) necessary to conduct
their respective businesses as conducted as of the date this
representation is made. Except as set forth in Schedule
3(o) , to the Company’s Knowledge (i) none of the
rights of the Company or any of its Subsidiaries or Foreign
Subsidiaries in its Intellectual Property have expired or
terminated, or are expected to expire or terminate within five
(5) years from the date of this Agreement, except to the
extent such termination could not and could not reasonably be
expected, individually or in the aggregate, to have a Material
Adverse Effect, (ii) there has been no infringement by the
Company or any of its Subsidiaries or Foreign Subsidiaries or any
of the Company’s or any of its Subsidiaries’ or Foreign
Subsidiaries’ licensors or licensees of any Intellectual
Property rights of others, (iii) there has been no
infringement by any third parties of any Intellectual Property
owned or licensed by the Company or any of its Subsidiaries or
Foreign Subsidiaries, or of any development of similar or identical
trade secrets or technical information by others, (iv) there
is no claim, action or proceeding against or being threatened
against, the Company, any of its Subsidiaries or Foreign
Subsidiaries or any of their respective licensors regarding their
Intellectual Property or infringement of other Intellectual
Property rights and there is no claim, action or proceeding against
or being threatened against the Company, any of its Subsidiaries or
Foreign Subsidiaries or any of their respective licensors regarding
their Intellectual Property or infringement of other Intellectual
Property rights, (v) there are no facts or circumstances that
could reasonably be expected to give rise to any of the foregoing,
(vi) there is no patent or patent application which contains
claims that interfere with the issued or pending claims of any of
the Intellectual Property owned or licensed by the Company or any
of its Subsidiaries or Foreign Subsidiaries, and (vii) none of
the technology employed by the Company or any of its Subsidiaries
or Foreign Subsidiaries has been obtained or is being used by the
Company or any of its Subsidiaries or Foreign Subsidiaries in
violation of any material contractual obligation binding on the
Company or any of its Subsidiaries or Foreign Subsidiaries or is
being used by any of the officers, directors or employees of the
Company or of its Subsidiaries or Foreign
15
Subsidiaries on behalf of
the Company or any of its Subsidiaries or Foreign Subsidiaries in
violation of the rights of any Person or Persons. The Company
and its Subsidiaries and, to the Company’s Knowledge, its
Foreign Subsidiaries, as applicable, have taken commercially
reasonable security measures to protect the secrecy,
confidentiality and the value of all of their material Intellectual
Property.
p.
Environmental
Laws . Except as set forth
on Schedule 3(p) , each of the Company and its Subsidiaries
and, to the Company’s Knowledge, its Foreign Subsidiaries
(i) is, and has at all times been, in compliance in all
material respects with any and all, and has not violated any,
Environmental Laws (as defined below), (ii) has no, and has
never had any, liability for failure to comply with any
Environmental Law, (iii) has received all permits, licenses or
other approvals required of it under applicable Environmental Laws
to conduct its business as presently conducted, and (iv) is in
compliance with all terms and conditions of any such permit,
license or approval.
q.
Insurance
. The
Company and each of its Subsidiaries, and, to the Company’s
Knowledge, each of its Foreign Subsidiaries, if and as applicable,
are insured by insurers of recognized financial responsibility
against such losses and risks and in such amounts as is prudent and
customary in the businesses in which the Company and its
Subsidiaries and its Foreign Subsidiaries are engaged. All of
the Company’s insurance policies are in full force and effect
and are valid, outstanding and enforceable, and all premiums with
respect thereto are currently paid and no basis exists for early
termination of any of such insurance policies on the part of the
insurer thereunder. None of Company or its Subsidiaries or,
to the Company’s Knowledge, its Foreign Subsidiaries, if
applicable, has failed to give any notice or present any claim
under any such insurance policies in due and timely fashion, and
there are no outstanding unpaid claims under any such insurance
policies. Neither the Company nor any such Subsidiary, or, to
the Company’s Knowledge, any Foreign Subsidiary has been
refused any insurance coverage sought or applied for, and neither
the Company nor any such Subsidiary, or, to the Company’s
Knowledge, any such Foreign Subsidiary, has any reason to believe
that it will not be able to renew its existing insurance coverage
as and when such coverage expires or to obtain similar coverage
from similar insurers as may be necessary to continue its business
at a cost that would not reasonably be expected to result in a
material increase in the Company’s current cost of such
insurance.
r.
Regulatory
Permits . The Company and its
Subsidiaries and, to the Company’s Knowledge, its Foreign
Subsidiaries, if applicable, possess all certificates,
authorizations, approvals, licenses and permits issued by the
appropriate federal, state or foreign regulatory authorities
necessary to conduct their respective businesses as conducted at
the time this representation is made (“ Permits ”), and neither the
Company nor any such Subsidiary or, to the Company’s
Knowledge, any such Foreign Subsidiary has received any notice of
proceedings relating to the revocation or modification of any such
Permit. The Company and its Subsidiaries and Foreign
Subsidiaries have no Knowledge that they will not be able to obtain
necessary Permits as and when necessary to enable the Company and
its Subsidiaries and Foreign Subsidiaries to conduct their
respective businesses.
s.
Principal
Market . The Company is not in
violation of any of the rules, regulations or requirements of the
OTC Bulletin Board (the “ Principal Market ”;
provided
16
however
, that, if after
the date of this Agreement the Common Stock is listed on a national
securities exchange or automated quotation system, the
“ Principal
Market ” shall mean such
national securities exchange) and has no Knowledge of any facts or
circumstances which would reasonably lead to suspension or
termination of the trading of the Common Stock on the Principal
Market in the foreseeable future. Since December 31,
2007, (i) the Company’s Common Stock has been quoted on
the Principal Market, (ii) trading in the Common Stock has not
been suspended by the SEC or on the Principal Market and
(iii) the Company has received no communication, written or
oral, from the SEC or the Principal Market regarding the suspension
or termination of the trading of the Common Stock on the Principal
Market.
t.
Tax
Status . The Company and
each of its Subsidiaries and, to the Company’s Knowledge,
each of its Foreign Subsidiaries, as applicable, (i) has made
or filed all federal, state and foreign income and all other tax
returns, reports and declarations required by any jurisdiction to
which it is subject, (ii) has paid all taxes and other
governmental assessments and charges shown or determined to be due
on such returns, reports and declarations, except those being
contested in good faith and for which the Company has made
appropriate reserves on its books, and (iii) has set aside on
its books provisions reasonably adequate for the payment of all
taxes for periods subsequent to the periods to which such returns,
reports or declarations (referred to in clause (i) above)
apply. There are no unpaid taxes claimed in writing to be due
from the Company or any of its Subsidiaries or, to the
Company’s Knowledge, any of its Foreign Subsidiaries by the
taxing authority of any jurisdiction which, individually or in the
aggregate, is expected to have a Material Adverse Effect, and there
is no basis for any such claim. Neither the Company nor any
of its Subsidiaries is a “United States real property holding
corporation” (“ USRPHC ”) as that term is
defined in Section 897(c)(2) of the Internal Revenue Code
of 1986, as amended, and the Treasury Regulations promulgated
thereunder.
u.
Transactions
With Affiliates . Except as set forth
on Schedule 3(u) or in the SEC Documents, no Related
Party of the Company or any of its Subsidiaries, or, to the
Company’s Knowledge, any of its Foreign Subsidiaries, nor any
Affiliate thereof, is presently, has been within the past three
years, or will be as a result of the transactions contemplated by
this Agreement and the other Transaction Documents, a party to any
transaction, contract, agreement, instrument, commitment,
understanding or other arrangement or relationship with the Company
or any of its Subsidiaries or, to the Company’s Knowledge,
any of its Foreign Subsidiaries, whether for the furnishing of
services to or by, providing for rental of real or personal
property to or from, or otherwise requiring payments or
consideration to or from any such Related Party. No Related
Party of the Company or any of its Subsidiaries, or, to the
Company’s Knowledge, any of its Foreign Subsidiaries, or any
of their respective Affiliates, has any direct or indirect
ownership interest in any Person (other than ownership of less than
2% of the outstanding common stock of a publicly traded
corporation) in which the Company or any of its Subsidiaries or, to
the Company’s Knowledge, any of its Foreign Subsidiaries has
any direct or indirect ownership interest or with which the Company
or any of its Subsidiaries or, to the Company’s Knowledge,
any of its Foreign Subsidiaries competes or has a business
relationship.
v.
Application of
Takeover Protections; Rights Agreement . The Company and its
board of directors have taken all necessary action, if any, in
order to render inapplicable any control share acquisition,
business combination, or other similar anti-takeover provision
under the Certificate of Incorporation or any certificates of
designations or the laws of the State
17
of Delaware to the
transactions contemplated by this Agreement, the Company’s
issuance of the Securities in accordance with the terms hereof and
any Buyer’s ownership and voting (in the case of the Shares)
of the Securities. The Company has not adopted a stockholder
rights plan or similar arrangement relating to accumulations of
beneficial ownership of Common Stock or a change in control of the
Company.
w.
Foreign
Corrupt Practices . Neither the Company,
nor any of its Subsidiaries, nor, to the Company’s Knowledge,
any of its Foreign Subsidiaries, nor any director, officer, agent,
employee or other person acting on behalf of the Company or any of
its Subsidiaries, nor, to the Company’s Knowledge, any of its
Foreign Subsidiaries has, in the course of its actions for, or on
behalf of, the Company, used any corporate funds for any unlawful
contribution, gift, entertainment or other unlawful expenses
relating to political activity; made any direct or indirect
unlawful payment to any foreign or domestic government official or
employee from corporate funds; violated or is in violation of any
provision of the U.S. Foreign Corrupt Practices Act of 1977, as
amended; or made any unlawful bribe, rebate, payoff, influence
payment, kickback or other unlawful payment to any foreign or
domestic government official or employee.
x.
Outstanding
Indebtedness; Liens . Except for the Prior Notes
and as set forth on Schedule 3(x) , payments of principal
and other payments due under the Notes will, upon issuance at the
Closing, rank senior to all other Indebtedness of the Company or
any of its Subsidiaries, or, to the Company’s Knowledge, any
of its Foreign Subsidiaries (in right of payment, whether with
respect of payment of redemptions, interest or damages or upon
liquidation or dissolution or otherwise) and, by virtue of their
secured position, to all trade account payables of the Company or
any of its Subsidiaries, or, to the Company’s Knowledge, any
of its Foreign Subsidiaries. The Notes will, upon issuance at
the Closing, rank pari passu with the Prior Notes in right of
payment, whether with respect of payment of redemptions, interest
or damages or upon liquidation or dissolution or otherwise.
Except for the Prior Notes and as set forth on Schedule 3(x)
, (i) neither the Company nor any of its Subsidiaries, nor, to
the Company’s Knowledge, any of its Foreign Subsidiaries has,
and upon consummation of the transactions contemplated hereby and
by the other Transaction Documents will not have, any outstanding
Indebtedness other than Permitted Indebtedness (as defined below),
(ii) there are no, and upon consummation of the transactions
contemplated hereby and by the other Transaction Documents there
will not
|